132 related articles for article (PubMed ID: 36270787)
1. Myocardial mechanics of percutaneous intramyocardial septal radiofrequency ablation.
Li J; Zhang J; Shi Y; Sievert H; Taub CC; Bertog S; Ta S; Changhui L; Senser E; Wang J; Hu R; Huang J; Ruan F; Han Y; Li X; Wang B; Zhao X; Liu J; Hsi DH; Liu L
Heart; 2023 Jan; 109(4):289-296. PubMed ID: 36270787
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy.
Liu L; Li J; Zuo L; Zhang J; Zhou M; Xu B; Hahn RT; Leon MB; Hsi DH; Ge J; Zhou X; Zhang J; Ge S; Xiong L
J Am Coll Cardiol; 2018 Oct; 72(16):1898-1909. PubMed ID: 30309466
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].
Liu LW; Zuo L; Zhou MY; Li J; Zhou XD; He GB; Zhang J; Zhang JZ; Liu B; Yang J; Xu B
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):284-290. PubMed ID: 31060187
[No Abstract] [Full Text] [Related]
4. Clinical value of 2D speckle tracking imaging in evaluating the effect of percutaneous intramyocardial septal radiofrequency ablation in patients with hypertrophic obstructive cardiomyopathy.
Qian D; Zhou X; Liu H; Cao L
J Clin Ultrasound; 2021 Jul; 49(6):554-562. PubMed ID: 33675543
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy.
Zhou M; Ta S; Hahn RT; Hsi DH; Leon MB; Hu R; Zhang J; Zuo L; Li J; Wang J; Wang B; Zhu X; Liu J; Han Y; Li X; Xu B; Zhang L; Hou L; Han C; Liu J; Liu L
JAMA Cardiol; 2022 May; 7(5):529-538. PubMed ID: 35353129
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular longitudinal systolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a long-term follow-up study focused on speckle tracking echocardiography.
Sommer A; Poulsen SH; Mogensen J; Thuesen L; Egeblad H
Eur J Echocardiogr; 2010 Dec; 11(10):883-8. PubMed ID: 20667848
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency septal reduction in symptomatic hypertrophic obstructive cardiomyopathy.
Crossen K; Jones M; Erikson C
Heart Rhythm; 2016 Sep; 13(9):1885-90. PubMed ID: 27132152
[TBL] [Abstract][Full Text] [Related]
8. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
[TBL] [Abstract][Full Text] [Related]
9. Electrocardiographic QRS voltage amplitude improvement by intramyocardial radiofrequency ablation in patients with hypertrophic obstructive cardiomyopathy and one year follow up.
Zuo L; Hsi DH; Zhang L; Zhang Q; Shao H; Liu B; Lei C; Ye C; Meng X; Zhang G; Zhou M; Li J; He Y; Guo J; Liu L
J Electrocardiol; 2020; 61():164-169. PubMed ID: 32721657
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up.
Ta S; Li J; Hsi DH; Hu R; Lei C; Shan B; Li W; Wang J; Wang B; Kang N; Li X; Liu J; Qi C; Huang J; Han Y; Ruan F; Zhang J; Liu L
Heart; 2024 May; 110(11):792-799. PubMed ID: 38388470
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound® technology to guide ablation.
Cooper RM; Shahzad A; Hasleton J; Digiovanni J; Hall MC; Todd DM; Modi S; Stables RH
Europace; 2016 Jan; 18(1):113-20. PubMed ID: 26541709
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous trans-apex intra-septal radiofrequency ablation of hypertrophic cardiomyopathy.
Zuo L; Sun C; Yang J; Liu B; Zhou M; Guo R; Yu S; Ge J; Xiong L; Liu L
Minim Invasive Ther Allied Technol; 2018 Apr; 27(2):97-100. PubMed ID: 28949276
[TBL] [Abstract][Full Text] [Related]
13. Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy.
Moravsky G; Bruchal-Garbicz B; Jamorski M; Ralph-Edwards A; Gruner C; Williams L; Woo A; Yang H; Laczay B; Rakowski H; Carasso S
J Am Soc Echocardiogr; 2013 Aug; 26(8):893-900. PubMed ID: 23800507
[TBL] [Abstract][Full Text] [Related]
14. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].
Qiao SB; Gao RL; You SJ; Yuan JS; Chen JL; Yang YJ
Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):210-2. PubMed ID: 16624154
[TBL] [Abstract][Full Text] [Related]
15. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
Seggewiss H; Faber L; Ziemssen P; Gleichmann U
Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
[TBL] [Abstract][Full Text] [Related]
16. Effect of septal ablation on regional diastolic dysfunction and diastolic asynchrony in patients with hypertrophic obstructive cardiomyopathy: a follow-up study using speckle tracking echocardiography.
Chen S; Duan F; Yuan J; Qiao S; Lv X; Hu F; Yang W; Zhang J; Yang Y
Echocardiography; 2013 May; 30(5):564-71. PubMed ID: 23305549
[TBL] [Abstract][Full Text] [Related]
17. First-in-man application of Liwen RF™ ablation system in the treatment of drug-resistant hypertrophic obstructive cardiomyopathy.
Wang Z; Zhao R; Sievert H; Ta S; Li J; Bertog S; Piayda K; Zhou M; Lei C; Li X; Liu J; Xu B; Feng B; Hu R; Liu L
Front Cardiovasc Med; 2022; 9():1028763. PubMed ID: 36440055
[TBL] [Abstract][Full Text] [Related]
18. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Veselka J; Honek T
Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
[TBL] [Abstract][Full Text] [Related]
19. Ablation of hypertrophic septum using radiofrequency energy: an alternative for gradient reduction in patient with hypertrophic obstructive cardiomyopathy?
Riedlbauchová L; Janoušek J; Veselka J
J Invasive Cardiol; 2013 Jun; 25(6):E128-32. PubMed ID: 23735367
[TBL] [Abstract][Full Text] [Related]
20. Reverse remodeling after percutaneous transluminal septal myocardial ablation in severe but asymptomatic LVOT obstruction (RASTA) study: Rationale and design of transcatheter septal reduction in asymptomatic patients with severe hypertrophic obstructive cardiomyopathy.
Arslan F; Akdim F; Ten Berg JM
Catheter Cardiovasc Interv; 2021 Feb; 97(3):488-492. PubMed ID: 32808736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
